Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Metabolic and Nutritional Responses to Acute High-intensity Interval Exercise Performed Under Hypoxic vs. Normoxic Conditions at Matched External Workload in Adults With Overweight and Obesity. (HYPOXHIIT)

Comparison of HIIT Exercise Under Hypoxic and Normoxic Conditions in Adults With Overweight or Obesity: Impact on Oxygen Consumption, Carbohydrate and Lipid Substrate Utilization, and Appetite During Recovery.

Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, HIIT (High-Intensity Interval Training) workouts are now recognized as fun and effective programs for promoting fat loss. To date, in overweight or obese individuals, only two studies mention the benefits of HIIT performed under hypoxia for modulating body composition, and more specifically, reducing the amount of adipose tissue. These studies hypothesize an increased energy expenditure under hypoxia associated with a transient loss of appetite. In order, to further investigate the adaptations following HIIT under hypoxia versus normoxia, we propose to compare, in acute conditions, two HIIT sessions (simulated hypoxia-normobaric vs. normoxia) in overweight or obese subjects. The objective of this assessment is to compare, during exercise and recovery (+2h), oxygen consumption, corresponding energy expenditure, and carbohydrate and lipid utilization in hypoxic versus normoxic conditions. Given the potential influence of hypoxia on appetite, spontaneous food intake and energy expenditure post-24h will also be measured. Finally, since pleasure and perceived exertion are key parameters in adherence to an adapted physical activity (APA) program, these two concepts will also be evaluated through the subjects' experiences.

Studieoversikt

Detaljert beskrivelse

Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, High-intensity interval training (HIIT) is now recognized as a well-tolerated, safe, and effective exercise modality for improving body composition. In 2016, our pioneering study demonstrated that HIIT is more effective than moderate-intensity continuous training (MICT) in inducing abdominal fat loss in postmenopausal women. A subsequent meta-analysis, conducted by our team in 2018 and encompassing 39 articles involving 617 participants, confirmed the significant effects of HIIT on reducing total and abdominal fat mass in overweight or obese individuals More recently, our work has shown significant results from HIIT + resistance training or HIIT cycling vs. running on improving body composition, and more specifically on reducing abdominal and visceral fat mass, in overweight or obese subjects.

With a focus on performance, HIIT has been combined with simulated hypoxia to maximize training adaptations, particularly to improve cardiovascular, respiratory, circulatory, hematological, and metabolic capacities at the muscular level. Live Low Train High (LLTH) allows athletes to maintain normoxia while being exposed to acute periods of hypoxia during training via hypoxic chambers (simulated altitude). More recently, research has explored the effects of HIIT under hypoxic conditions in patients with metabolic disorders and/or physical deconditioning, focusing primarily on cardiovascular and ventilatory adaptations. To date, in overweight or obese individuals, only three studies investigated the benefit of HIIT under simulated hypoxia for modulating body composition, and more specifically for reducing total or abdominal fat. These studies generally hypothesize a higher energy expenditure during hypoxia, associated with a transient loss of appetite that may be linked to hormonal disturbances, central nervous system adaptability, or metabolic flexibility altering hunger and satiety signals.

In parallel with these hypotheses, hypoxia stimulates HIF-1 production, thus promoting a shift from oxidative metabolism to glycolysis. At the same external mechanical load, the increased use of carbohydrates via glycolysis, combined with increased cardiovascular stress, should promote, during the recovery phase, greater oxygen consumption and lipid oxidation following a hypoxic session. To date, no study has yet evaluated these hypotheses by comparing these parameters following two acute HIIT sessions performed under normoxia or hypoxia.

The aim is to compare the influence of these two sessions on oxygen consumption, the corresponding energy expenditure, and carbohydrate and lipid utilization during recovery (+2h). Given the potential influence of hypoxia on appetite, food intake and spontaneous energy expenditure post-24h will also be measured. Finally, since enjoyment and perceived exertion are crucial parameters for adherence to an adapted physical activity (APA) program, these two concepts will also be assessed through the participants' experiences.

The authors propose the following hypotheses:

Main hypothesis:

  1. Lipid oxidation (g/min) during recovery (+2h) will be higher post-hypoxic session.

    Secondary hypotheses:

  2. Oxygen consumption and energy expenditure will be increased during post-hypoxic session recovery.

4/ Energy intake from the post-exercise meal may be lower post-hypoxic condition.

5/ The effort will be perceived as slightly more difficult in hypoxia due to increased cardiovascular demand.

Studietype

Intervensjonell

Registrering (Faktiske)

18

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Allier
      • Bellerive-sur-Allier, Allier, Frankrike, 03321
        • CREPS Auvergne Rhône-Alpes / Vichy

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

- overweight or obesity (BMI between 25 kg/m2 and 35 kg/m2)

Exclusion Criteria:

  • medical contraindications to intense physical activity
  • taking ß-blocker
  • diabete
  • women taking hormonal replacement therapy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: High Intensity Interval Exercise - Normoxia
HIIE in normoxia
Cycling HIIE in Normoxia: 60 x [8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax]
Eksperimentell: High Intensity Interval Exercise - Hypoxia
HIIE in hypoxia
Cycling HIIE in Hypoxia (FiO2: 15%): 60 x [8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax]

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Lipid oxidation after the exercise session (nromoxia and hypoxia).
Tidsramme: Measurement during two hours after the end of the exercise
Determination of lipid and carbohydrate oxidation after the exercise (HIIE normoxia and hypoxia). Lipid aoxidation is measured from oxygen and carbon dioxide consumption (Metamax 3D Cortex).
Measurement during two hours after the end of the exercise

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Oxygen consumption during the recovery period
Tidsramme: Two hours after the end of the exercise
Determination of oxygen consumption 2 hours after the exercise session (HIIE normoxia and hypoxia). Determination from Metamax (3D Cortex).
Two hours after the end of the exercise
Energy intakes 24 hours after the exercise
Tidsramme: 24 hours post exercise
Evaluation of energy intakes after the exercise session (HIIE normoxia and HIIE hypoxia) during 24 hours (from questionnaires)
24 hours post exercise
Appetite
Tidsramme: Before exercise and after exercise (+0 min, +60 min, and +120 min).
Feelings of appetite are measured using a visual appetite scale immediately before and after exercise (+0 min, +60 min, and +120 min).
Before exercise and after exercise (+0 min, +60 min, and +120 min).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. november 2024

Primær fullføring (Faktiske)

1. september 2026

Studiet fullført (Faktiske)

1. september 2026

Datoer for studieregistrering

Først innsendt

5. september 2026

Først innsendt som oppfylte QC-kriteriene

5. september 2026

Først lagt ut (Faktiske)

11. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere